Blog Profile / Reuters: Health


URL :http://uk.reuters.com/news/archive/healthNewsMolt
Filed Under:Health
Posts on Regator:3835
Posts / Week:67.5
Archived Since:August 20, 2016

Blog Post Archive

Alnylam's genetic disease drug succeeds key study, shares soar

(Reuters) - Alnylam Pharmaceuticals Inc's drug to treat a rare genetic disease cleared a key study, moving the company closer to filing a marketing application for the drug, which is part of a new class of medicines that block disease-causing proteins.

Trump endorses latest Republican bill to dismantle Obamacare

WASHINGTON (Reuters) - President Donald Trump on Wednesday threw his weight behind congressional Republicans' latest bill to dismantle Obamacare and called on party senators to vote for the healthcare overhaul.

Alnylam's genetic disease drug clears key study, shares soar

(Reuters) - Alnylam Pharmaceuticals Inc said its drug to treat patients suffering from a rare genetic disease met the main goal in a late-stage study, moving the company closer to filing a marketing application for the drug in late 2017.

Alnylam's genetic disease drug meets main goal in key study

(Reuters) - Alnylam Pharmaceuticals Inc said on Wednesday its drug met the main goal in a late-stage study in patients suffering from a life-threatening genetic disease.

GSK's new triple lung drug beats other modern inhalers in study

LONDON (Reuters) - GlaxoSmithKline produced clinical data on Wednesday showing its newly approved three-in-one inhaler reduced life-threatening attacks in chronic obstructive pulmonary disease (COPD) patients more than other modern treatments.

Shire, Shionogi's ADHD drug for adults clears late-stage trial in Japan

TOKYO (Reuters) - Shire Plc and Shionogi & Co Ltd said a drug to treat ADHD in adults had met its main goal in a late-stage trial in Japan, bringing it one step closer to approval in the world's third-biggest market for ADHD treatme...

Novartis's Rydapt wins EU approval for AML, other diseases

ZURICH (Reuters) - Swiss drugmaker Novartis on Wednesday said it had won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML) and other rare diseases, adding to U.S. approvals it secured in April.

UK backs Opdivo for lung cancer after Bristol-Myers cuts price

LONDON (Reuters) - Bristol-Myers Squibb's immunotherapy drug Opdivo has been recommended for some patients with lung cancer by Britain's healthcare cost watchdog NICE after the drugmaker agreed a discounted price.

As clock ticks, Republicans try to move ahead on Obamacare repeal

WASHINGTON (Reuters) - The Trump administration and top U.S. Senate Republicans pushed on Tuesday for action on a bill to dismantle Obamacare, but time was running out and they were still hunting for the votes needed to pass their latest attempt to gut the 2010 healthcare law.

What can studies tell us about whole grains and the heart?

(Reuters Health) - Scientists haven’t yet proved beyond a doubt that a diet rich in whole grains is healthy for the heart, a research review suggests.

Poor sleep associated with higher risk of chronic pain

(Reuters Health) - People who sleep poorly may be more likely to develop a chronic pain condition and have worse physical health, a study from the UK suggests.

'Shocking' disregard for safety in U.S. meningitis case -prosecutor

BOSTON (Reuters) - A federal prosecutor on Tuesday accused a Massachusetts pharmacist charged with murder for his role in a deadly 2012 U.S. meningitis outbreak of showing a "shocking" disregard for patients' lives, while his lawyer argued the man was no killer.

US Military surgeons in Afghanistan treat civilian injuries

(Reuters Health) - At U.S. military facilities in Afghanistan, roughly half of the surgeries done for local civilians during more than a decade of war have been for non-combat injuries and health problems, a recent study suggests.

Obamacare repeal must move quickly, says Senate's McConnell

WASHINGTON (Reuters) - The U.S. Senate's top Republican on Tuesday urged quick action on a bill to repeal Obamacare but stopped short of promising to bring it to the Senate floor for a vote, as the clock ticks down on the latest attempt to kill the 2010 healthcare law.

Pharmacist in deadly U.S. meningitis outbreak disregarded safety -prosecutor

BOSTON (Reuters) - A Massachusetts pharmacist charged with murder for his role in a deadly 2012 U.S. meningitis outbreak showed "shocking" disregard for safety standards, a federal prosecutor said at the start of the trial on Tuesda...

U.S. appeals court blocks San Francisco ordinance on soda health warnings

SAN FRANCISCO (Reuters) - A U.S. appeals court sided with the beverage industry on Tuesday, granting its request to block a San Francisco ordinance mandating health warnings for soda and other sugary drinks.

Energy-efficient green buildings may emit hazardous chemicals

(Reuters Health) - Newly renovated low-income housing units in Boston earned awards for green design and building but flunked indoor air-quality tests, a new study shows.

Appeals court blocks San Francisco's ordinance for soda health warnings

(Reuters) - A U.S. appeals court on Tuesday sided with the beverage industry, granting a preliminary injunction to block a San Francisco ordinance mandating health warnings for soda.

Massachusetts pharmacist faces trial over 2012 meningitis outbreak

BOSTON (Reuters) - A Massachusetts pharmacist is due in court on Tuesday to face trial on charges including murder stemming from his role in a 2012 fungal meningitis outbreak that sickened hundreds of people and killed 76 across the United States.

U.S. Senate's McConnell urges quick action on Obamacare repeal bill

WASHINGTON (Reuters) - U.S. Senate Majority Leader Mitch McConnell on Tuesday urged quick action on a recently introduced bill to repeal Obamacare and said it had a lot of support.

Copyright © 2015 Regator, LLC